Dr. Jessica Allegretti is an attending gastroenterologist at the Brigham and Women’s Hospital Crohn’s and Colitis Center, where she serves as the center’s Director of Clinical Trials as well as the hospital’s Fecal Transplant Program Director. Dr. Allegretti’s research focuses on the intestinal microbiome and the consequences of its derangement, with the goal of understanding the role dysbiosis plays in microbial associated diseases, specifically clostridium difficile infections (CDI) and inflammatory bowel disease (IBD). Additionally she has lead several clinical trials investigating the role of FMT in other chronic diseases including obesity and primary sclerosis cholangitis.